Proathlete Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Buy |
16,343
+362
| +2% | +$8.78K | 0.13% | 47 |
|
|
2025
Q1 | $405K | Buy |
15,981
+1,147
| +8% | +$29.1K | 0.15% | 45 |
|
|
2024
Q4 | $394K | Buy |
14,834
+171
| +1% | +$4.54K | 0.15% | 47 |
|
|
2024
Q3 | $424K | Buy |
14,663
+85
| +0.6% | +$2.46K | 0.17% | 46 |
|
|
2024
Q2 | $408K | Sell |
14,578
-16
| -0.1% | -$448 | 0.19% | 46 |
|
|
2024
Q1 | $405K | Buy |
14,594
+44
| +0.3% | +$1.22K | 0.22% | 44 |
|
|
2023
Q4 | $419K | Buy |
+14,550
| New | +$419K | 0.25% | 44 |
|